AMD Shares Slide Despite Earnings Beat as Cautious Revenue Outlook Weighs on Stock 
Sony Q3 Profit Jumps on Gaming and Image Sensors, Full-Year Outlook Raised 
Nvidia, ByteDance, and the U.S.-China AI Chip Standoff Over H200 Exports 
Nvidia Nears $20 Billion OpenAI Investment as AI Funding Race Intensifies 
Anthropic Eyes $350 Billion Valuation as AI Funding and Share Sale Accelerate 
OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering 
TSMC Eyes 3nm Chip Production in Japan with $17 Billion Kumamoto Investment 
Uber Ordered to Pay $8.5 Million in Bellwether Sexual Assault Lawsuit 
Alphabet’s Massive AI Spending Surge Signals Confidence in Google’s Growth Engine 
Once Upon a Farm Raises Nearly $198 Million in IPO, Valued at Over $724 Million 
Nvidia CEO Jensen Huang Says AI Investment Boom Is Just Beginning as NVDA Shares Surge 
Australian Scandium Project Backed by Richard Friedland Poised to Support U.S. Critical Minerals Stockpile 
Global PC Makers Eye Chinese Memory Chip Suppliers Amid Ongoing Supply Crunch 
SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates 
FDA Targets Hims & Hers Over $49 Weight-Loss Pill, Raising Legal and Safety Concerns 
Prudential Financial Reports Higher Q4 Profit on Strong Underwriting and Investment Gains 
Instagram Outage Disrupts Thousands of U.S. Users 
ALTAMONTE SPRINGS, Fla., Sept. 28, 2017 -- Approved by the U.S. FDA in 2005, the Class IV K-Laser utilizes pre-determined wavelengths of near-infrared and red light to increase circulation and decrease pain, swelling and inflammation indicative of neuropathies. Following a series of successful clinical trials, the FDA further cleared K-Laser therapy for facilitating repair and regeneration of damaged tissue due to the laser's ability to draw nutrients, oxygen and water into inflamed soft tissues. Proponents of K-Laser therapy Drs. Danielle and Roy Clarke of Beyond Chiropractic in Altamonte Springs, FL have been successfully using K-Laser technology as an alternative to surgery and pain medications when treating symptoms of neuropathy, specifically diabetic neuropathy and chemo-related neuropathy.
Neuropathy Response to K-Laser Therapy
Disorders of the nervous system and/or nerve damage may cause neuropathic pain, a type of burning, shooting pain often severe and chronic. Diabetic neuropathy arises when high blood glucose levels erode the integrity of nerves and blood vessels. People receiving chemotherapy may also suffer peripheral neuropathy when taking powerful, anti-carcinogenic medications. Although chemotherapy is essential for eradicating cancer cells and tumors, it can have a medically negative affect on nerves connecting the spinal cord to organs, skin and muscles.
A type of biomodifying laser energy, K-Laser increases cellular metabolic activity while improving transport of nutrients in and out of a cell's membrane. By triggering production of ATP (a chemical necessary for cell health), K-Laser works to relieve nerve inflammation, reduce neuropathic pain and facilitate blood flow throughout the affected area. In addition, ongoing clinical research shows the K-Laser to be a safe and effective therapeutic modality treatment for diabetic neuropathy, chemotherapy-related neuropathy and many other chronic pain conditions such as arthritis, bursitis, Bell's Palsy and plantar fasciitis.
Drs. Danielle and Roy Clarke of Beyond Chiropractic offer K-Laser therapy for treating nervous and musculoskeletal disorders. Located at 460 E Altamonte Dr. in Altamonte Springs, FL, Beyond Chiropractic can be reached by calling 407-261-1001.
